Data from a late-stage study shows that co-administering GSK's RSV and Shingles vaccines together was as effective as giving each separately.
Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.
The latest research suggests that the recombinant shingles vaccine may offer additional benefits. It appears to reduce the ...